What is the EBITDA yield for Liquidia Corporation (LQDA)?

The EBITDA yield for LQDA stock is 7.86%.

Liquidia (LQDA) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the EBITDA yield high or low?

The EBITDA yield of 7.86% is 519% above its estimated 1-year average of 1.27%, near the high end of its estimated 1-year range (0.51%–7.86%).

As of 2026-10-06T16:33:11.065Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:33:11.065Z.

Quote observation: 2026-10-06T16:30:37.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: 170,268,000
Quote market capitalization: 2,322,801,946
Total debt · period ending 2026-06-30: 128,944,000
Cash · period ending 2026-06-30: 284,181,000

FMP input reference: 295890ca45b9fb7c845dc9b7cfc12ce3e82df22f7cd737cbd4420fef5fb5231a

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

LQDA EBITDA Yield Metrics

EBITDA YIELD

7.86%

EBITDA YIELD AVG TTM

N/A

EBITDA YIELD AVG 3Y

N/A

EBITDA YIELD AVG 5Y

N/A

EBITDA YIELD AVG 10Y

N/A

EBITDA YIELD AVG 15Y

N/A

EBITDA YIELD AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

6.42%

median of 201 covered companies

CURRENT VS SECTOR MEDIAN

+22.43%

vs the sector median at left

LQDA Competitors' EBITDA Yield

LQDA

Liquidia Corporation

Current

Market Cap

$2.32B

EBITDA Yield

7.86%

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NRIX

Nurix Therapeutics, Inc.

vs LQDA

Market Cap

$2.36B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRMY

Harmony Biosciences Holdings, Inc.

vs LQDA

Market Cap

$2.29B

EBITDA Yield

13.49%

TTM Avg

15.75%

3Y Avg

13.75%

5Y Avg

10.29%

ADMA

ADMA Biologics, Inc.

vs LQDA

Market Cap

$2.38B

EBITDA Yield

9.25%

TTM Avg

7.20%

3Y Avg

4.06%

5Y Avg

4.06%

ALMR

Alamar Biosciences, Inc.

vs LQDA

Market Cap

$2.39B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MRVI

Maravai LifeSciences Holdings, Inc.

vs LQDA

Market Cap

$2.28B

EBITDA Yield

6.34%

TTM Avg

11.96%

3Y Avg

10.61%

5Y Avg

16.98%

CLOV

Clover Health Investments, Corp.

vs LQDA

Market Cap

$2.41B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RXRX

Recursion Pharmaceuticals, Inc.

vs LQDA

Market Cap

$2.42B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRON

Disc Medicine, Inc.

vs LQDA

Market Cap

$2.45B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHVS

Pharvaris N.V.

vs LQDA

Market Cap

$2.14B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Liquidia Corporation (LQDA)	$2.32B	7.86%	N/A	N/A	N/A
Nurix Therapeutics, Inc. (NRIX)vs ›	$2.36B	N/A	N/A	N/A	N/A
Harmony Biosciences Holdings, Inc. (HRMY)vs ›	$2.29B	13.49%	15.75%	13.75%	10.29%
ADMA Biologics, Inc. (ADMA)vs ›	$2.38B	9.25%	7.20%	4.06%	4.06%
Alamar Biosciences, Inc. (ALMR)vs ›	$2.39B	N/A	N/A	N/A	N/A
Maravai LifeSciences Holdings, Inc. (MRVI)vs ›	$2.28B	6.34%	11.96%	10.61%	16.98%
Clover Health Investments, Corp. (CLOV)vs ›	$2.41B	N/A	N/A	N/A	N/A
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.42B	N/A	N/A	N/A	N/A
Disc Medicine, Inc. (IRON)vs ›	$2.45B	N/A	N/A	N/A	N/A
Pharvaris N.V. (PHVS)vs ›	$2.14B	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield FAQ

What is the EBITDA yield for Liquidia Corporation (LQDA)?: The EBITDA yield for LQDA stock is 7.86%.
Is Liquidia Corporation's EBITDA yield high or low?: The EBITDA yield of 7.86% is 519% above its estimated 1-year average of 1.27%, near the high end of its estimated 1-year range (0.51%–7.86%).

LQDA EBITDA Yield History

DATE	EBITDA YIELD
2026-10-05	6.43%
2026-10-02	6.19%
2026-10-01	6.35%
2026-09-30	5.85%
2026-09-29	2.43%
2026-09-28	2.33%
2026-09-25	2.51%
2026-09-24	2.42%
2026-09-23	2.55%
2026-09-22	2.50%
2026-09-21	2.59%
2026-09-18	2.57%
2026-09-17	2.51%
2026-09-16	2.51%
2026-09-15	2.62%
2026-09-14	2.63%
2026-09-11	2.58%
2026-09-10	2.53%
2026-09-09	2.48%
2026-09-08	2.54%
2026-09-04	2.50%
2026-09-03	2.50%
2026-09-02	2.46%
2026-09-01	2.57%
2026-08-31	2.52%
2026-08-28	2.54%
2026-08-27	2.45%
2026-08-26	2.40%
2026-08-25	2.44%
2026-08-24	2.44%
2026-08-21	2.50%
2026-08-20	2.42%
2026-08-19	2.28%
2026-08-18	2.31%
2026-08-17	2.20%
2026-08-14	2.30%
2026-08-13	2.38%
2026-08-12	0.59%
2026-08-11	0.53%
2026-08-10	0.51%
2026-08-07	0.52%
2026-08-06	0.52%
2026-08-05	0.53%
2026-08-04	0.53%
2026-08-03	0.56%
2026-07-31	0.56%
2026-07-30	0.54%
2026-07-29	0.54%
2026-07-28	0.54%
2026-07-27	0.55%
2026-07-24	0.54%
2026-07-23	0.53%
2026-07-22	0.54%
2026-07-21	0.58%
2026-07-20	0.61%
2026-07-17	0.59%
2026-07-16	0.62%
2026-07-15	0.60%
2026-07-14	0.61%
2026-07-13	0.66%
2026-07-10	0.60%
2026-07-09	0.57%
2026-07-08	0.59%
2026-07-07	0.58%
2026-07-06	0.59%
2026-07-02	0.59%
2026-07-01	0.59%
2026-06-30	0.59%
2026-06-29	0.62%
2026-06-26	0.60%
2026-06-25	0.61%
2026-06-24	0.62%
2026-06-23	0.63%
2026-06-22	0.62%
2026-06-18	0.66%
2026-06-17	0.68%
2026-06-16	0.69%
2026-06-15	0.65%
2026-06-12	0.66%
2026-06-11	0.65%
2026-06-10	0.72%
2026-06-09	0.73%
2026-06-08	0.73%
2026-06-05	0.76%
2026-06-04	0.75%
2026-06-03	0.84%
2026-06-02	0.85%
2026-06-01	0.80%
2026-05-29	0.76%
2026-05-28	0.76%
2026-05-27	0.76%
2026-05-26	0.78%
2026-05-22	0.77%
2026-05-21	0.76%
2026-05-20	0.76%
2026-05-19	0.78%
2026-05-18	0.82%
2026-05-15	0.82%
2026-05-14	0.79%
2026-05-13	0.81%
2026-05-12	0.83%

EBITDA Yield: 7.86%

LQDA EBITDA Yield Chart

LQDA EBITDA Yield Metrics

LQDA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

EBITDA Yield FAQ

LQDA EBITDA Yield History

Related Metrics